Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lidereau

Showing results (131-140 of 152) with videos related to

Pageof 16
Sort By:
Biochimie|July 1, 1988
Genetic variability of proto-oncogenes for breast cancer risk and prognosisR Lidereau, D Mathieu-Mahul, C Escot, et al.
International Journal of Cancer|August 17, 1999
Histological type and syncytial growth pattern affect E-cadherin expression in a multifactorial analysis of a combined panel of sporadic and BRCA1-associated breast cancersJ Jacquemier, F Eisinger, C Noguès, et al.
Endocrine-Related Cancer|September 17, 2004
Inter-laboratory quality control for hormone-dependent gene expression in human breast tumors using real-time reverse transcription-polymerase chain reactionP de Cremoux, I Bieche, C Tran-Perennou, et al.
Cancer Research|May 1, 1991
Somatic allelic deletion of nm23 in human cancerA Leone, O W McBride, A Weston, et al.
Oncogene|March 3, 1998
Low frequency of TSG101/CC2 gene alterations in invasive human breast cancersQ Wang, K Driouch, S Courtois, et al.
Journal of Molecular Endocrinology|October 3, 2007
Oligonucleotide microarray analysis of estrogen receptor alpha-positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifenS Tozlu-Kara, V Roux, C Andrieu, et al.
International Journal of Cancer|June 17, 1999
Novel indications for BRCA1 screening using individual clinical and morphological featuresF Eisinger, C Noguès, J M Guinebretière, et al.
Analytical and Quantitative Cytology and Histology|November 24, 1999
Alteration of Met protooncogene product expression and prognosis in breast carcinomasI Tsarfaty, W G Alvord, J H Resau, et al.
Pathologie-Biologie|March 12, 2003
[A new model of human prostate cancer, the PAC120 xenograft]M E Legrier, G de Pinieux, F Poirson-Bichat, et al.
Journal of Medical Genetics|April 22, 2008
Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigeneC Bonnet, S Krieger, M Vezain, et al.
Pageof 16

Showing results (131-140 of 152) with videos related to

Sort By:
Pageof 16
Biochimie|July 1, 1988
Genetic variability of proto-oncogenes for breast cancer risk and prognosisR Lidereau, D Mathieu-Mahul, C Escot, et al.
International Journal of Cancer|August 17, 1999
Histological type and syncytial growth pattern affect E-cadherin expression in a multifactorial analysis of a combined panel of sporadic and BRCA1-associated breast cancersJ Jacquemier, F Eisinger, C Noguès, et al.
Endocrine-Related Cancer|September 17, 2004
Inter-laboratory quality control for hormone-dependent gene expression in human breast tumors using real-time reverse transcription-polymerase chain reactionP de Cremoux, I Bieche, C Tran-Perennou, et al.
Cancer Research|May 1, 1991
Somatic allelic deletion of nm23 in human cancerA Leone, O W McBride, A Weston, et al.
Oncogene|March 3, 1998
Low frequency of TSG101/CC2 gene alterations in invasive human breast cancersQ Wang, K Driouch, S Courtois, et al.
Journal of Molecular Endocrinology|October 3, 2007
Oligonucleotide microarray analysis of estrogen receptor alpha-positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifenS Tozlu-Kara, V Roux, C Andrieu, et al.
International Journal of Cancer|June 17, 1999
Novel indications for BRCA1 screening using individual clinical and morphological featuresF Eisinger, C Noguès, J M Guinebretière, et al.
Analytical and Quantitative Cytology and Histology|November 24, 1999
Alteration of Met protooncogene product expression and prognosis in breast carcinomasI Tsarfaty, W G Alvord, J H Resau, et al.
Pathologie-Biologie|March 12, 2003
[A new model of human prostate cancer, the PAC120 xenograft]M E Legrier, G de Pinieux, F Poirson-Bichat, et al.
Journal of Medical Genetics|April 22, 2008
Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigeneC Bonnet, S Krieger, M Vezain, et al.
Pageof 16